Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01437566
Title	Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor Therapy
Recruitment	Completed
Gender	female
Phase	Phase II
Variant Requirements	Yes
Sponsors	Genentech, Inc.
Indications	Her2-receptor negative breast cancer
Therapies	Apitolisib Fulvestrant Pictilisib
Age Groups:	adult
Covered Countries	USA \| NZL \| ITA \| ISR \| GBR \| FRA \| ESP \| DNK \| DEU \| CAN \| BEL \| AUS \| ARG